β-catenin - A linchpin in colorectal carcinogenesis?

American Journal of Pathology

Volumn 160, Issue 2, 2002, Pages 389-401

  Wong, Newton Alexander Chiang Shuek ^a   Pignatelli, Massimo ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; AXIN; BETA CATENIN; CYCLIN D1; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; GASTRIN; GLYCOGEN SYNTHASE KINASE 3BETA; GLYCOPROTEIN P; HERMES ANTIGEN; HOMEODOMAIN PROTEIN; LYMPHOID ENHANCER FACTOR 1; MATRILYSIN; MUCIN 1; MYC PROTEIN; ONCOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE C BETA; PROTEIN P53; RAS PROTEIN; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA; UROKINASE; UVOMORULIN; VITAMIN D;

APOPTOSIS; CARCINOGENESIS; CELL JUNCTION; COLON POLYPOSIS; COLORECTAL CANCER; COLORECTAL CARCINOMA; GENETIC DISORDER; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0036174452     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64856-0     Document Type: Review

References (140)

1. Uvomorulin-catenin complex: Cytoplasmic anchorage of a Ca2+-dependent cell adhesion molecule
2. β-catenin signaling and cancer
3. Regulation of β-catenin signaling in the Wnt pathway
4. Colorectal cancer: Molecules and populations
5. The interactions of APC, E-cadherin and β-catenin in tumour development and progression
6. Cell-cell adhesion in invasion and metastasis of carcinomas
7. Association of the APC tumor suppressor protein with catenins
8. E-cadherin and APC compete for the interaction with β-catenin and the cytoskeleton
9. Reciprocity between membranous and nuclear expression of β-catenin in colorectal tumors
10. Phosphorylation and free pool of β-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration
11. Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells
12. Defects in the regulation of β-catenin in colorectal cancer
13. Siah-1, SIP and Ebi collaborate in a novel pathway for β-catenin degradation linked to p53 responses
14. Siah-1 mediates a novel β-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein
15. Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer
16. Synergy between tumor suppressor APC and the β-catenin-Tcf4 target Tcf1
17. Inhibition of β-catenin-mediated transactivation by cadherin derivatives
18. Expression of the HGF/SF receptor, c-met, and its ligand in human colorectal cancers
19. Study of c-erbB-2 protein and epidermal growth factor receptor expression and DNA ploidy pattern in colorectal carcinoma
20. Expression of several growth factors and their receptor genes in human colon carcinomas
21. Expression of antisense epidermal growth factor receptor mRNA downmodulates the malignant behaviour of human colon cancer cells
22. Regulation of spreading and growth of colon cancer cells by hepatocyte growth factor
23. The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton
24. Hepatocyte growth factor/scatter factor disrupts epithelial tumour cell-cell adhesion: Involvement of β-catenin
25. c-erbB-2 gene product directly associates with β-catenin and plakoglobin
26. p21ras: An oncoprotein functioning in growth factor-inducing signal transduction
27. Conserved expression of intestinal trefoil factor in the human colonic adenoma-carcinoma sequence
28. Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia
29. Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells
30. Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis
31. Expression of insulin-like growth factor-1 receptor in human colorectal cancer
32. Overexpression of protein kinase C βII induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis
33. The polycystic kidney disease 1 gene product modulates Wnt signaling
34. Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids
35. Protein kinase isoforms in human and rat colonic mucosa
36. Polycystic kidney disease: The complete structure of the PKD1 gene and its protein
37. Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins
38. Transforming growth factor-beta: The breaking open of a black box
39. Modulation of differentiation and proliferation of human colon carcinoma cells by transforming growth factor beta 1 and beta 2
40. Identification of a member of the MAPKKK family as a potential mediator of TGF β signal transduction
41. The TAK1-NLK-MAPK-related pathway antagonizes signaling between β-catenin and transcription factor TCF
42. Interaction between Wnt and TGFβ signaling pathways during formation of Spemann's organizer
43. Transforming growth factor β stimulation of colorectal cancer cell lines: Type II receptor bypass and changes in adhesion molecule expression
44. Differential effects of retinoic acid on growth and apoptosis in human colon cancer cell lines associated with the induction of retinoic acid receptor β
45. Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line
46. Cross-regulation of β-catenin-LEF/TCF and retinoid signaling pathways
47. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma
48. Interaction of the DF3/MUC1 breast carcinoma-associated antigen and β-catenin in cell adhesion
49. Interaction between glycogen synthase kinase 3β with the DF3/MUC1 carcinoma-associated antigen and β-catenin
50. The organization, promoter analysis, and expression of the human PPARγ gene
51. Dietary factors and risk for colon cancer
52. Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice
53. min/+ mice
54. Relationship of β-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min mice
55. The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: Evidence of different mechanisms of action
56. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer
57. Activation of β-catenin-Tcf signaling in colon cancer by mutations of β-catenin or APC
58. β-catenin mutations in cell lines established from human colorectal cancers
59. Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated β-catenin
60. Intestinal polyposis in mice with a dominant stable mutation of the β-catenin gene
61. Study of neoplasia in the Min mouse
62. Familial adenomatous polyposis. From bedside to benchside
63. The adenomatous polyposis coli (APC) tumor suppressor
64. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
65. Sequence variants of the axin gene in breast, colon, and other cancers: An analysis of mutations that interfere with GSK3 binding
66. Cloning of the human homolog of conductin (AXIN2), a gene mapping to chromosome 17q23-q24
67. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling
68. Evidence for the involvement of the Wnt 2 gene in human colorectal cancer
69. Up-regulation of macrophage wnt gene expression in adenomacarcinoma progression of human colorectal cancer
70. Nuclear overexpression of the oncoprotein β-catenin in colorectal cancer is localized predominantly at the invasion front
71. A new member of the frizzled family from Drosophila functions as a Wingless receptor
72. A novel frizzled gene identified in human esophageal carcinoma mediates APC/β-catenin signals
73. The human T-cell transcription factor-4 gene: Structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines
74. Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability
75. Identification of c-MYC as a target of the APC pathway
76. Suppression of deregulated c-MYC expression in human colon carcinoma cells by chromosome 5 transfer
77. Over-expression of the c-myc proto-oncogene in colorectal carcinoma
78. Expression of nuclear β-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas
79. γ-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin
80. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis
81. Expression of cyclins D1 and E in human colon adenocarcinomas
82. β-catenin regulates expression of cyclin D1 in colon carcinoma cells
83. The cyclin D1 is the target gene of the β-catenin/LEF-1 pathway
84. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane induced tumors: Effects on mitogen-activated protein kinase, cyclo-oxygenase-2, and cyclin D1
85. Gastrin is a target of the β-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis
86. The role of gastrin in the adenoma: Carcinoma sequence in the colon
87. Expression but incomplete maturation of progastrin in colorectal carcinomas
88. The prevention of colorectal cancer by aspirin use
89. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
90. Δ716 knockout mice by inhibition of cyclooxygenase 2
91. Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational level
92. Transcriptional activation of Cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells
93. Differential expression of prostaglandin endoperoxide H synthase-2 and formation of activated β-catenin-LEF-1 transcription complex in mouse colonic epithelial cells contrasting in Apc
94. Expression and localization of matrix-degrading metalloproteinases during colorectal carcinogenesis
95. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin
96. β-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer
97. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors
98. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis
99. Plasminogen activation by receptor bound urokinase. A kinetic study with both cell-associated and isolated receptor
100. Aasen AO: Antigen levels of urokinase plasminogen activator and its receptor at the tumor-host interface of colorectal adenocarcinomas are related to tumor aggressiveness
101. Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers
102. Target genes of β-catenin-T cell factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas
103. CD44 cell adhesion molecules
104. Expression of variant CD44-messenger RNA in colorectal adenocar cinomas and adenomatous polyps in humans
105. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins
106. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 mutation
107. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway
108. MDR1/P-glycoprotein expression in colorectal cancer
109. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/β-catenin complex in early colorectal carcinogenesis
110. Deregulation of apoptosis in colorectal carcinoma: Theoretical and therapeutic implications
111. Excess β-catenin promotes accumulation of transcriptionally active p53
112. Microinjection of monoclonal antibody PAb421 into human SW480 colorectal carcinoma cells restores the transcription activation function to mutant p53
113. The inhibitors of apoptosis (IAPs) and their emerging role in cancer
114. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
115. Nuclear localization of beta-catenin and loss of apical brush border actin in cystic tubules of bcl-2 -/- mice
116. Downregulation of the colon tumour-suppressor homeobox gene Cdx-2 by oncogenic ras
117. Cdx1 promotes differentiation in a rat intestinal epithelial cell line
118. Homeosis and intestinal tumours in Cdx2 mutant mice
119. Wnt/β-catenin signaling regulates the expression of the homeobox gene Cdx1 in embryonic intestine
120. CDX2 is mutated in a colorectal cancer with normal APC/β-catenin signaling
121. Cdx-2 homeodomain protein expression in rat and human colorectal adenoma and carcinoma
122. CDX1 protein expression in normal, metaplastic, and neoplastic human alimentary tract epithelium
123. The human T cell transcription factor-1 gene. Structure, localization, and promoter characterization
124. The dual role of cytoskeletal anchor proteins in cell adhesion and signal transduction
125. Butyrate regulates E-cadherin transcription, isoform expression and intracellular position in colon cancer cells
126. Butyrate and the colonocyte. Implications for neoplasia
127. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines
128. E-cadherin binding prevents β-catenin nuclear localization and β-catenin/LEF1-mediated transactivation
129. Nuclear localization of β-catenin by interaction with transcription factor LEF-1
130. Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers
131. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers
132. α-catenin inhibits β-catenin signaling by preventing formation of a β-catenin*T-cell factor*DNA complex
133. β-catenin expression in primary and metastatic colorectal carcinoma
134. DNA mismatch repair and colorectal cancer
135. Frequent mutation of β-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer
136. Molecular carcinogenesis in ulcerative colitis-related and sporadic colorectal cancer-differences and similarities
137. Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of β-catenin
138. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis
139. The Wnt/Wg signal transducer β-catenin controls fibronectin expression
140. Mechanisms of colon cancer binding to substratum and cells